The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Fungal allergy in asthma-state of the art and research needs
Open accessAbstract
Sensitization to fungi and long term or uncontrolled fungal infection are associated with poor control of asthma, the likelihood of more severe disease and complications such as bronchiectasis and chronic pulmonary aspergillosis. Modelling suggests that >6.5 million people have severe asthma with fungal sensitizations (SAFS), up to 50% of adult asthmatics attending secondary care have fungal sensitization, and an estimated 4.8 million adults have allergic bronchopulmonary aspergillosis (ABPA). There is much uncertainty about which fungi and fungal allergens are relevant to asthma, the natural history of sensitisation to fungi, if there is an exposure response relationship for fungal allergy, and the pathogenesis and frequency of exacerbations and complications. Genetic associations have been described but only weakly linked to phenotypes. The evidence base for most management strategies in ABPA, SAFS and related conditions is weak. Yet straightforward clinical practice guidelines for management are required. The role of environmental monitoring and optimal means of controlling disease to prevent disability and complications are not yet clear. In this paper we set out the key evidence supporting the role of fungal exposure, sensitisation and infection in asthmatics, what is understood about pathogenesis and natural history and identify the numerous areas for research studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Patterns of fungal interactions with humans, illustrating different host pathogen interactions, based on the host damage response framework[9].](https://figures.cochat.ai/paper-figures/b9f6eead36974711a77ef2b7657e5597/fungal-allergy-in-asthma-state-of-the-art-and-research-needs-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mean ABPA prevalence rate of 2.5% in adult asthmatics reflects studies done in new asthma referrals to a specialist in South Africa, New Zealand, Iran, Ireland, Saudi Arabia and China, translating to over 4.8 million cases of ABPA in adults [137].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291 · cited 1×
“The Global Burden of Disease 2010 project estimated that asthma wa s ranked 43rd globally for years life lost [62], although 15th and 20th in Oceania and Easter n Europe respectively; 15th globally in terms of prevalence with an estimated 334 million people affected; 14th in terms of years lived with disability [63];…”
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987 · cited 1×
“Bio-statistical approaches to measuring heterogeneity in asthma have suggested that asthma as broadly defined is comprised of a number of distinct endotypes, not all of which have obvious AHR or variable airflow obstruction [11,12], and improvement in symptoms of asthma are not always reflected in better physiological…”
BackgroundSelf-citationDisordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Johansson, S. G. O., Hourihane, J. O., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T., Kowalski, M. L., Mygind, N., Ring, J., van Cauwenberge, P., et al. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.t01-1-00001.x · Cited by 1,723 · cited 1×
“As fungi are complex eukaryotes, all forms of allergic immune response [8] should be considered as potentially leading to fungal allergy, although the most well-recognised clinical responses, such as asthma and rhinitis caused by Alternaria alternata, are mediated in a straightforward immunoglobulin (Ig) E/ TH2 manner.”
BackgroundUrban, C. F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., Brinkmann, V., Jungblut, P. R., & Zychlinsky, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000639 · Cited by 1,673 · cited 1×
“Macrophages phagocytose fungi, neutrophils phagocytose and/ or release their granule contents and form DNA neutrophil extracellular traps (NETs) to entangle, immobilize and kill the fungus, a process involving neutrophilderived calprotectin [118,119].”
BackgroundAsthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160 · cited 2×
“While ABPA was accepted as an endotype of asthma by another EAACI Task Force [12], SAFS was not and remains a pragmatic definition to enable an antifungal therapy trial.”
BackgroundSelf-citationChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“Autosomal recessive IL-17RA and autosomal dominant IL-17F deficiencies have been reported in chronic mucocutaneous candidiasis (CMC) patients [131].”
Background
Research works printed but not linked: 3
- 10.1111/j.1398-9995.2001.00002.x-i1 · doi:10.1111/j.1398-9995.2001.00002.x-i1 · Paper page
- Miller PW, 1996, Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis, Am J Hum Genet, 59, 45
- Foundation ERSEL, 2003, European Lung White Book
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“The major assumptions made were based on previous studies of SAFS and ABPA; Severe asthma is thought to affect about 10% of adults and in other countries, 33–70% are sensitised to fungi [137] and that 2.”
BackgroundMethodSelf-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
“depends on patient response, severity of disease and exacerbation frequency, drug adverse effects, and the emergence of antifungal resistance [637, 639, 641].”
BackgroundSelf-citationThe Role of Lung and Gut Microbiota in the Pathology of Asthma
Barcik, W., Boutin, R. C. T., Sokolowska, M., & Finlay, B. B. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.007 · Cited by 613
How to bolster the antifungal pipeline
Denning, D. W., & Bromley, M. J. (2015) · Science · doi:10.1126/science.aaa6097 · Cited by 481
Self-citationPaulussen, C., Hallsworth, J. E., Álvarez‐Pérez, S., Nierman, W. C., Hamill, P. G., Blain, D., Rediers, H., & Lievens, B. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12367 · Cited by 334
Metadata
- Authors
- Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Leicester (GB)
- University of Tübingen (DE)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Department of Medical Sciences “M. Aresu” University of Cagliari Cagliari Italy
- Biology & Diversity of Emerging Eukaryotic Pathogens (BDEEP) Center for Infection and Immunity of Lille (CIIL), INSERM U1019, CNRS UMR8204 IFR142 Lille Pasteur Institute Lille Nord de France University (EA4547) Lille France
- North Estonia Medical Centre (EE)
- Corresponding author
- Denning, David W
- Venue
- Clinical and Translational Allergy
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 4
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2045-7022 (ISSN-L)
- PMC
- PMC4005466
- OpenAlex
- W2096172855
- Cited by
- 357
- References
- 224
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 17 · 2023: 24 · 2022: 34 · 2021: 44 · 2020: 27 · 2019: 34 · 2018: 32 · 2017: 36 · 2016: 39 · 2015: 32 · 2014: 9
- FWCI
- 25.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical and Translational Allergy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Figshare (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10030)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- fungal allergy, asthma, allergic bronchopulmonary aspergillosis, fungal sensitization, fungal allergens, chronic pulmonary aspergillosis, bronchiectasis, asthma exacerbations, exposure-response relationship, genetic association, asthma management, environmental monitoring, research needs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal allergy in asthma-state of the art and research needs. https://app.cochat.ai/papers/10.1186/2045-7022-4-14
- The paper
- Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S. (2014). Fungal allergy in asthma-state of the art and research needs. Clinical and Translational Allergy. https://doi.org/10.1186/2045-7022-4-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.